IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells https://www.biorxiv.org/content/10.1101/2023.06.09.544165v1?med=mas
IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells https://www.biorxiv.org/content/10.1101/2023.06.09.544165v1?med=mas